InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by TAKANASHI KEN. Officer active across 2 companies, notably Satsuma Pharmaceuticals, Inc.. In total, 2 reports have been published. Split: 1 buy · 0 sell. Total volume traded: €18.8m. History available since 6 June 2023. The latest transaction was disclosed on 12 August 2024 (Attribution). Regulator: SEC (Form 4). The full history is free.
2 of 2 declarations